The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia. Candan O, Demirtas D, Yanik AM, Atagunduz I, et al. Ann Hematol 2023 Sep 20. doi: 10.1007/s00277-023-05456.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Candan O, Demirtas D, Yanik AM, Atagunduz I, et al. The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia. Ann Hematol 2023 Sep 20. doi: 10.1007/s00277-023-05456.
PMID: 37731146